These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. EU agrees deal on cheaper drugs for developing world. Watson R. BMJ; 2003 Jun 07; 326(7401):1229. PubMed ID: 12791716 [No Abstract] [Full Text] [Related]
27. Drugs for the poor of the Third World: consumption and distribution. Mills A, Walker GJ. J Trop Med Hyg; 1983 Aug 07; 86(4):139-45. PubMed ID: 6668634 [No Abstract] [Full Text] [Related]
28. Better access to drugs in developing countries is accelerating resistance. Mayor S. BMJ; 2010 Jun 17; 340():c3234. PubMed ID: 20558519 [No Abstract] [Full Text] [Related]
32. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E. Chic J Int Law; 2002 Jun 17; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
34. Access to essential drugs. Dev World Bioeth; 2001 Nov 17; 1(2):89-92. PubMed ID: 12870517 [No Abstract] [Full Text] [Related]
35. [Drugs in the 3d World. Every profession has its share of responsibility]. Rosenkvist I. Sygeplejersken; 1983 Jun 01; 83(21):24-6. PubMed ID: 6555952 [No Abstract] [Full Text] [Related]
37. Essential medicines in the Third World. D'Arcy PF. Br Med J (Clin Res Ed); 1984 Oct 13; 289(6450):982-4. PubMed ID: 6435751 [No Abstract] [Full Text] [Related]
39. No deal in sight on cheap drugs for poor countries. Fleck F. BMJ; 2003 Mar 01; 326(7387):465. PubMed ID: 12609924 [No Abstract] [Full Text] [Related]